- Acquisition adds GALE-401 (Anagrelide CR) to expand Galena's product pipeline.
- Phase 2 clinical trial expected to begin in mid-2014 with GALE-401 to treat Essential Thrombocythemia (ET), an orphan myeloproliferative disorder.
Here's a technical look at how to trade some of the most active stocks on the market right now.
The inevitable failure of Galena Biopharma's breast cancer vaccine NeuVax was apparent in shoddy clinical data presented four years ago. On Wednesday, the bear call on Galena was proven correct.
Galena (GALE) stock closed sharply higher on Wednesday after its breast cancer treatment received a Fast Track designation from the FDA.